These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 38685731)

  • 1. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
    Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL
    Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms.
    Browne PD; Cold F; Petersen AM; Halkjær SI; Christensen AH; Günther S; Hestbjerg Hansen L
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 34074214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation alters gut phage communities in a clinical trial for obesity.
    Zuppi M; Vatanen T; Wilson BC; Golovina E; Portlock T; Cutfield WS; Vickers MH; O'Sullivan JM
    Microbiome; 2024 Jul; 12(1):122. PubMed ID: 38970126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial.
    Yu EW; Gao L; Stastka P; Cheney MC; Mahabamunuge J; Torres Soto M; Ford CB; Bryant JA; Henn MR; Hohmann EL
    PLoS Med; 2020 Mar; 17(3):e1003051. PubMed ID: 32150549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial.
    Mocanu V; Zhang Z; Deehan EC; Kao DH; Hotte N; Karmali S; Birch DW; Samarasinghe KK; Walter J; Madsen KL
    Nat Med; 2021 Jul; 27(7):1272-1279. PubMed ID: 34226737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity.
    Wilson BC; Vatanen T; Jayasinghe TN; Leong KSW; Derraik JGB; Albert BB; Chiavaroli V; Svirskis DM; Beck KL; Conlon CA; Jiang Y; Schierding W; Holland DJ; Cutfield WS; O'Sullivan JM
    Microbiome; 2021 May; 9(1):107. PubMed ID: 33985595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time.
    de Groot P; Scheithauer T; Bakker GJ; Prodan A; Levin E; Khan MT; Herrema H; Ackermans M; Serlie MJM; de Brauw M; Levels JHM; Sales A; Gerdes VE; Ståhlman M; Schimmel AWM; Dallinga-Thie G; Bergman JJ; Holleman F; Hoekstra JBL; Groen A; Bäckhed F; Nieuwdorp M
    Gut; 2020 Mar; 69(3):502-512. PubMed ID: 31147381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species- and strain-level assessment using
    Benítez-Páez A; Hartstra AV; Nieuwdorp M; Sanz Y
    Gut Microbes; 2022; 14(1):2078621. PubMed ID: 35604764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disentangle beneficial effects of strain engraftment after fecal microbiota transplantation in subjects with MetSyn.
    van der Vossen EWJ; Davids M; Voermans B; Wortelboer K; Hartstra AV; Koopen AM; de Groot P; Levin E; Nieuwdorp M
    Gut Microbes; 2024; 16(1):2388295. PubMed ID: 39163526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplantation Donor and Dietary Fiber Intervention Collectively Contribute to Gut Health in a Mouse Model.
    Zhong Y; Cao J; Ma Y; Zhang Y; Liu J; Wang H
    Front Immunol; 2022; 13():842669. PubMed ID: 35185934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
    Staley C; Kaiser T; Vaughn BP; Graiziger CT; Hamilton MJ; Rehman TU; Song K; Khoruts A; Sadowsky MJ
    Microbiome; 2018 Sep; 6(1):166. PubMed ID: 30227892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials.
    Proença IM; Allegretti JR; Bernardo WM; de Moura DTH; Ponte Neto AM; Matsubayashi CO; Flor MM; Kotinda APST; de Moura EGH
    Nutr Res; 2020 Nov; 83():1-14. PubMed ID: 32987284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition.
    Kootte RS; Levin E; Salojärvi J; Smits LP; Hartstra AV; Udayappan SD; Hermes G; Bouter KE; Koopen AM; Holst JJ; Knop FK; Blaak EE; Zhao J; Smidt H; Harms AC; Hankemeijer T; Bergman JJGHM; Romijn HA; Schaap FG; Olde Damink SWM; Ackermans MT; Dallinga-Thie GM; Zoetendal E; de Vos WM; Serlie MJ; Stroes ESG; Groen AK; Nieuwdorp M
    Cell Metab; 2017 Oct; 26(4):611-619.e6. PubMed ID: 28978426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis.
    Paramsothy S; Nielsen S; Kamm MA; Deshpande NP; Faith JJ; Clemente JC; Paramsothy R; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Lin E; Borody TJ; Wilkins MR; Colombel JF; Mitchell HM; Kaakoush NO
    Gastroenterology; 2019 Apr; 156(5):1440-1454.e2. PubMed ID: 30529583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fecal microbiota transplantation in subjects with irritable bowel syndrome are mirrored by changes in gut microbiome.
    Goll R; Johnsen PH; Hjerde E; Diab J; Valle PC; Hilpusch F; Cavanagh JP
    Gut Microbes; 2020 Nov; 12(1):1794263. PubMed ID: 32991818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation.
    Devarakonda SLS; Superdock DK; Ren J; Johnson LM; Loinard-González AAP; Poole AC
    Gut Microbes; 2024; 16(1):2367301. PubMed ID: 38913541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome.
    van der Vossen EWJ; Bastos D; Stols-Gonçalves D; de Goffau MC; Davids M; Pereira JPB; Li Yim AYF; Henneman P; Netea MG; de Vos WM; de Jonge W; Groen AK; Nieuwdorp M; Levin E
    Gut Microbes; 2021; 13(1):1993513. PubMed ID: 34747338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
    Chu ND; Crothers JW; Nguyen LTT; Kearney SM; Smith MB; Kassam Z; Collins C; Xavier R; Moses PL; Alm EJ
    mBio; 2021 Aug; 12(4):e0097521. PubMed ID: 34281401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome.
    Hartstra AV; Schüppel V; Imangaliyev S; Schrantee A; Prodan A; Collard D; Levin E; Dallinga-Thie G; Ackermans MT; Winkelmeijer M; Havik SR; Metwaly A; Lagkouvardos I; Nier A; Bergheim I; Heikenwalder M; Dunkel A; Nederveen AJ; Liebisch G; Mancano G; Claus SP; Benítez-Páez A; la Fleur SE; Bergman JJ; Gerdes V; Sanz Y; Booij J; Kemper E; Groen AK; Serlie MJ; Haller D; Nieuwdorp M
    Mol Metab; 2020 Dec; 42():101076. PubMed ID: 32916306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.